Table 1 Group demographics and study characteristics
Author, Year | No. of Ankles | Intervention | Comparator(s) | Average Age ± SD | Average Follow-Up | LOE | MQOE |
|---|---|---|---|---|---|---|---|
Gormeli et al., 2015 [41] | 40 | MF/HA group Arthroscopic MF and subsequent HA injection | MF/PRP group Arthroscopic MF and subsequent PRP injection MF/saline group Arthroscopic MF and subsequent saline injection | MF/HA group 39.7 ± 8.7 years MF/PRP group 38.6 ± 9.1 years MF/saline group 40.3 ± 9.4 years | 15.3 months (range, 11–25) | 1 | 81 |
Doral et al., 2012 [43] | 57 | MF/HA group Arthroscopic MF and subsequent weekly HA injection for three weeks | MF group Arthroscopic MF alone | MF/HA group Not reported MF group Not reported Combined 40.5 ± 13.0 years | ≥24 months | 2 | 83 |
Shang et al., 2016 [42] | 35 | MF/HA group Arthroscopic MF and subsequent weekly HA injection for three weeks | MF group Arthroscopic MF alone | MF/HA group 34.7 ± 8.7 years MF group 36.6 ± 10.7 years | MF/HA group 10.4 months (SD, 1.3) MF group 10.7 months (SD, 1.1) | 1 | 77 |